Voyager Therapeutics (VYGR) EBT Margin (2016 - 2025)
Historic EBT Margin for Voyager Therapeutics (VYGR) over the last 11 years, with Q3 2025 value amounting to 207.53%.
- Voyager Therapeutics' EBT Margin fell 1709800.0% to 207.53% in Q3 2025 from the same period last year, while for Sep 2025 it was 401.76%, marking a year-over-year decrease of 4181100.0%. This contributed to the annual value of 80.42% for FY2024, which is 1339100.0% down from last year.
- According to the latest figures from Q3 2025, Voyager Therapeutics' EBT Margin is 207.53%, which was down 1709800.0% from 641.67% recorded in Q2 2025.
- Voyager Therapeutics' 5-year EBT Margin high stood at 1523.23% for Q4 2022, and its period low was 3239.97% during Q1 2022.
- Over the past 5 years, Voyager Therapeutics' median EBT Margin value was 393.32% (recorded in 2021), while the average stood at 599.31%.
- Its EBT Margin has fluctuated over the past 5 years, first plummeted by -28466500bps in 2022, then soared by 33228700bps in 2023.
- Voyager Therapeutics' EBT Margin (Quarter) stood at 18.02% in 2021, then skyrocketed by 8353bps to 1523.23% in 2022, then crashed by -96bps to 63.53% in 2023, then plummeted by -950bps to 540.03% in 2024, then soared by 62bps to 207.53% in 2025.
- Its EBT Margin stands at 207.53% for Q3 2025, versus 641.67% for Q2 2025 and 476.68% for Q1 2025.